Erin McEvoy

As discussions about the federal scheduling of cannabis continue, efforts by medical cannabis advocates are intensifying. One such advocate is Americans for Safe Access (ASA), a nonprofit organization founded by patients for patients. Since 2002, ASA has been championing the rights of medical cannabis patients and has recently launched new campaigns and strategies to refocus attention on patient needs. In this interview, Steph Sherer, founder and president of ASA, reflects on past successes in medical cannabis advocacy, shares her perspective on recent cannabis and hemp policymaking, and outlines the next steps for advancing a unified medical cannabis message on Capitol Hill—a message that could bring about the changes patients have long awaited.

In this interview, Raphael Wechsler, Founder of Wroots Botanicals LLC, Sustainability Lead for Studio Voltaire LLC, and former Director of Partnerships and Operations and Sustainability Committee Chair for the Cannabis Association of New York, discusses the challenges of cannabis packaging and its sustainability in the industry.

The latest webinar in this series explored challenges and solutions in the current and future landscape of cannabis policies and regulation.

The hearing concerning the federal scheduling of cannabis will potentially take place in December 2024.

As we prepare to publish our full Back to Basics: Soil’s Crucial Role in Cannabis Cultivation interview, let’s revisit some of the tips and insights from our cultivation experts, Adam Jacques, a world-renowned cannabis geneticist and Zacariah L. Hildenbrand, a research Professor at the University of Texas at El Paso.

As we prepare to publish our full Back to Basics: Soil’s Crucial Role in Cannabis Cultivation interview, let’s revisit some of the tips and insights from our cultivation experts, Adam Jacques, a world-renowned cannabis geneticist and Zacariah L. Hildenbrand, a research Professor at the University of Texas at El Paso.

Voters in North Dakota will see recreational cannabis on the ballot this November.

One study analyzed nearly 100 CBD products to test the accuracy of advertised cannabinoid content.

Researchers sought to provide community-based evidence in the co-use of opioids and cannabis among people who inject drugs.

A new study demonstrates the neuroprotective properties of the supplement N-Acetylcysteine against effects of cannabis exposure in adolescence.

This month’s Healer webinar provided a deep dive into several studies on cannabis for various conditions.

This presentation provided a comprehensive overview of cannabigerol (CBG), highlighting two studies on its effects on anxiety, stress, and pain.

In light of recent headlines concerning cannabis laboratories throughout the country, Cannabis Science and Technology reached out to Douglas Duncan, Laboratory Director of Kairos Labs in Detroit, MI and member of our Editorial Advisory Board for more information. In this interview, Duncan shares his perspectives on lab shopping, major challenges in the industry today, and innovations in cannabis testing laboratories for the future. He also shares insights into consumer practices and the potential effects of a federal rescheduling of cannabis.

In honor of National CBD Day on August 8 (8/8/24), we compiled eight articles on various aspects of cannabidiol (CBD).

Read three factoids about hemp and its seeds on nutrition, history, and certification.

The majority of comments on the scheduling of cannabis favored change, though several other aspects of cannabis policy remain to be addressed.

The 23rd episode in the monthly webinar series discusses vape manufacturing, consumers, and solutions to health and safety risks.

The discussion surrounding intoxicating the manufacture and sale of hemp-derived cannabinoids continues with more proposals and challenges.

California’s bill creating new restrictions on intoxicating hemp products has prompted responses citing negative impacts on patients and businesses.

In reversal of recent developments, officials in Thailand have signaled that cannabis will not be re-criminalized.

A recently published study examined data on thousands of pregnancies, maternal health outcomes, and cannabis use.

Americans for Safe Access, a medical cannabis patient advocacy organization, held a briefing on the final day of the comment period for the proposed rulemaking on cannabis.

Cannabis Science and Technology is pleased to announce the addition of Hannia Mendoza-Dickey to its Editorial Advisory Board.

This month’s webinar discussed studies conducted on cannabis and psychedelics for various conditions including anxiety and autism spectrum disorder.

Check out some of our most popular content from the first six months of the year 2024!

In this interview, Steve Fuhr of SciPhy Systems discusses the upcoming impacts cannabis extraction.

This latest episode of the monthly webinar series untangled the various aspects currently facing the US hemp industry.

In this interview, Steve Fuhr of SciPhy Systems, discusses cannabis extraction methods, products, and research.

Cannabis Science Conference Spring was held in Kansas City, Missouri from May 7-9, 2024. Here, we provide highlights from this exciting event.

In the ongoing dialogue surrounding cannabis, the testimonials of medical cannabis patients stand as crucial reminders of its impacts and benefits in the industry. For a deep dive into this topic, Cannabis Science and Technology sat down with Nikki Lawley, founder of Nikki and the Plant, LLC, for her take on the challenges patients face today in the midst of discussions of industry developments such as the rescheduling of cannabis. A traumatic brain injury survivor, Lawley now actively supports medical cannabis access and engages diverse audiences through her journey as a pediatric nurse-turned-patient-and-advocate. Here, she explains the importance of educating people about cannabis, the need for patient perspective in cannabis policy decisions, and the benefits of empathetic approaches to medical cannabis use.